Comments*

 
NYAS Beta

  • Annals of the New York Academy of Sciences

  • Annals Main Guidelines and Contacts | Subscriptions | Forthcoming
  • Annals

    Climate Change Adaptation in New York City

    Building a Risk Management Response

    Prepared by the New York City Panel on Climate Change, the report in this Annals volume outlines the need for early and ongoing adaptation actions to climate change in New York.

    In this Volume



    The New York City Panel on Climate Change 2009 report.

  • Recent Annals 

    January 2010

    Climate Change Adaptation in New York City: Building a Risk Management Response

    New York City Panel on Climate Change
    2009 Report

    Funded through a grant from the Rockefeller Foundation and modeled on the Intergovernmental Panel on Climate Change, the New York City Panel on Climate Change (NPCC) was launched in August 2008 as part of the City’s long-term sustainability plan (PlaNYC) to advise on issues related to climate change and adaptation. This volume presents the NPCC report issued in February 2009.

    Forthcoming volume

    December 2009

    Cytokine Therapies: Novel Approaches for Clinical Indications

    Edited by Raymond P. Donnelly (Center for Drug Evaluation & Research (CDER), Food and Drug Administration, Rockville, Maryland)

    This volume includes presentations by experts from academia, industry and government on the scientific and clinical basis for the successes and failures of recombinant cytokines and cytokine antagonists as therapeutic agents.

    December 2009

    Chernobyl: Consequences of the Catastrophe for People and the Environment

    Written by Alexey V. Yablokov (Center for Russian Environmental Policy, Moscow, Russia), Vassily B. Nesterenko, and Alexey V. Nesterenko (Institute of Radiation Safety, Minsk, Belarus). Consulting Editor Janette D. Sherman-Nevinger (Environmental Institute, Western Michigan University, Kalamazoo, Michigan).

    This volume contains a comprehensive summary of all the scientific literature related to the Chernobyl disaster, including a vast array of reports published in Russian and Ukrainian.

    November 2009

    Pepducin symposium explores a new approach to GPCR modulation

    Jacquelyn Miller (MacDougall Biomedical Communications, Wellesley, Massachusetts), Anika Agarwal and Athan Kuliopulos (Tufts Medical Center, Boston, Massachusetts), Lakshmi A. Devi (Mount Sinai School of Medicine, New York, New York), Kellen Fontanini and James A. Hamilton (Boston University School of Medicine, Boston, Massachusetts), Jean-Philippe Pin (University of Montpellier, Montpellier, France), Denis C. Shields (The University College of Dublin, Dublin, Ireland), C. Arnold Spek (University of Amsterdam, Amsterdam, the Netherlands), Thomas P. Sakmar (The Rockefeller University, New York, New York), and Stephen W. Hunt III (Ascent Therapeutics, Cambridge, Massachusetts).

    The inaugural Pepducin Science Symposium in Cambridge, Massachusetts on March 8–9, 2009 provided the opportunity for an international group of scientists to present and discuss how pepducins modulate G protein–coupled receptor-related research.

    Free access meeting report

    November 2009

    Biomarkers in Brain Disease

    Edited by Simon Lovestone (King's College, University of London)

    Experts discuss the latest advances in biomarker technologies and biomarker development for brain disorders, and the logistical, regulatory, and funding challenges experienced by scientists working on clinical trials for biomarkers.

    November 2009

    Glucocorticoids and Mood: Clinical Manifestations, Risk Factors, and Molecular Mechanisms

    Edited by Lewis L. Judd (Department of Psychiatry, University of California, San Diego) and Esther Sternberg (Integrative Neural Immune Program, Section on Neuroendocrine Immunology and Behavior, NIMH, NIH, Bethesda, Maryland)

    New basic research provides important insights into possible mechanisms of action that promote negative sequelae in vulnerable and susceptible patients who receive glucocorticoid treatment.

    October 2009

    Hypoxia and Consequences: From Molecule to Malady

    Edited by Chris Peers (School of Medicine, University of Leeds, Leeds, UK), Gabriel G. Haddad (University of California, San Diego, California), and Navdeep S. Chandel (Northwestern University, Evanston, Illinois)

    This volume explores the transcriptional and pathophysiological responses to hypoxia and of the sensing mechanisms responsible for detection of oxygen level changes in the body.

    October 2009

    Natural Genetic Engineering and Natural Genome Editing

    Edited by Günther Witzany (Telos-Philosophische Praxis, Bürmoos, Austria)

    Scientists working on genome organization, genome restructuring, genome formatting, and virus research discuss how to integrate these discoveries into the basic understanding of evolution, development, and disease.

    September 2009

    Hematopoietic Stem Cells VII

    Edited by Lothar Kanz and Katja C. Weisel (University of Tübingen, Tübingen, Germany), John E. Dick (University of Toronto, Toronto, Ontario, Canada), and Willem E. Fibbe (Leiden University Medical Center, Leiden, The Netherlands)

    A fundamental property of hematopoetic stem cells is the capacity to self-renew; this volume presents recent developments and clinical implications in hematopoietic stem cell research.

    September 2009

    Oligonucleotide Therapeutics: 4th Annual Meeting

    Edited by John Rossi (Beckman Research Institute of the City of Hope, Duarte, California), Michael Gait (Medical Research Council, Cambridge, UK), and Fritz Eckstein (Max-Planck Institute for Experimental Medicine, Göttingen, Germany)

    Basic researchers in molecular biology, cell biology, nucleic acid chemistry, pharmacology, and applied therapeutics present new technologies in the field of oligonucleotide research.

    full archives